Diagnostic Yield of Routine Enteropathogenic Stool Tests in Pediatric Ulcerative Colitis

Faith D Ihekweazu1, Avanthi Ajjarapu2, Richard Kellermayer2

  • 1Section of Pediatric Gastroenterology, Baylor College of Medicine, USDA/ARS Children's Nutrition Research Center, Texas Children's Hospital, Houston, TX, USA faith.ihekweazu@bcm.edu.

Insights

Routine stool testing for Clostridium difficile infection is recommended in pediatric ulcerative colitis (UC) flares. Other infectious stool studies are less common but may be relevant in select cases.

Area of Science:

  • Pediatric Gastroenterology
  • Infectious Diseases
  • Inflammatory Bowel Disease

Background:

  • Excluding infectious etiologies is crucial before altering immunosuppressive therapy in ulcerative colitis (UC) exacerbations.
  • Diagnostic yield of routine infectious stool studies in pediatric UC patients requires evaluation.

Purpose of the Study:

  • To determine the diagnostic yield of routine infectious stool studies in pediatric UC patients.
  • To assess the prevalence of various infections during UC flares.

Main Methods:

  • Retrospective review of 152 pediatric UC patients.
  • Analysis of infectious stool studies performed between January 2003 and December 2009.
  • Data collection on test types, results, and patient records up to July 2014.

Main Results:

  • Clostridium difficile was positive in 13.6% of 354 tests.
  • Bacterial cultures were positive in 1.8% (non-typhoid Salmonella).
  • Ova and Parasites were positive in 1.3%; Adenovirus PCR in 7.7%.

Conclusions:

  • Routine Clostridium difficile screening is strongly recommended for pediatric UC flares.
  • Other bacterial and parasitic infections are uncommon, but Salmonella warrants consideration.
  • Non-specific fecal viral tests have questionable utility in UC patients without comorbidities.
Abstract

Related Concept Videos

Serum Laboratory Studies, Stool Test, Breath Test01:30

Serum Laboratory Studies, Stool Test, Breath Test

Gastrointestinal (GI) diagnostic studies are pivotal in confirming, ruling out, diagnosing, or staging various diseases, including cancers. Following diagnosis, allocating time for discussions with the patient and providing informational resources is crucial. Diagnostic assessments of the GI tract often occur in outpatient settings like endoscopy suites or GI labs. Preparation for these tests may include dietary restrictions, fasting, liquid bowel preparations, laxatives, enemas, and the...
1.1K
Peptic Ulcer Disease III: Clinical Manifestations and Diagnostic Studies01:28

Peptic Ulcer Disease III: Clinical Manifestations and Diagnostic Studies

Peptic ulcer disease (PUD) presents with diverse symptoms depending on the location and severity of the ulcer. Clinical manifestations of peptic ulcer include dull pain and a burning sensation in the mid-epigastric region.
Few clinical manifestations differentiate gastric ulcers from duodenal ulcers. Distinctions in the location, timing, and pain relief are crucial for healthcare providers in differentiating between gastric and duodenal ulcers during clinical assessments.
782
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy01:30

Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy

Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
1.0K
Irritable Bowel Syndrome II: Clinical Features and Diagnostic Evaluation01:30

Irritable Bowel Syndrome II: Clinical Features and Diagnostic Evaluation

Irritable Bowel Syndrome II: Clinical Features and Diagnostic Evaluation
Irritable Bowel Syndrome (IBS) is classified into subtypes based on the predominant bowel habits as determined by the Bristol Stool Form Scale (BSFS). The subtypes are:
1.0K